BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 17907195)

  • 1. T cells expressing allograft inflammatory factor 1 display increased chemotaxis and induce a profibrotic phenotype in normal fibroblasts in vitro.
    Del Galdo F; Jiménez SA
    Arthritis Rheum; 2007 Oct; 56(10):3478-88. PubMed ID: 17907195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of allograft inflammatory factor 1 in tissues from patients with systemic sclerosis and in vitro differential expression of its isoforms in response to transforming growth factor beta.
    Del Galdo F; Maul GG; Jiménez SA; Artlett CM
    Arthritis Rheum; 2006 Aug; 54(8):2616-25. PubMed ID: 16868985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha.
    Chizzolini C; Parel Y; De Luca C; Tyndall A; Akesson A; Scheja A; Dayer JM
    Arthritis Rheum; 2003 Sep; 48(9):2593-604. PubMed ID: 13130479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allograft inflammatory factor-1 is overexpressed and induces fibroblast chemotaxis in the skin of sclerodermatous GVHD in a murine model.
    Yamamoto A; Ashihara E; Nakagawa Y; Obayashi H; Ohta M; Hara H; Adachi T; Seno T; Kadoya M; Hamaguchi M; Ishino H; Kohno M; Maekawa T; Kawahito Y
    Immunol Lett; 2011 Mar; 135(1-2):144-50. PubMed ID: 21040744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monocyte chemoattractant protein 1 released from glycosaminoglycans mediates its profibrotic effects in systemic sclerosis via the release of interleukin-4 from T cells.
    Distler JH; Jüngel A; Caretto D; Schulze-Horsel U; Kowal-Bielecka O; Gay RE; Michel BA; Müller-Ladner U; Kalden JR; Gay S; Distler O
    Arthritis Rheum; 2006 Jan; 54(1):214-25. PubMed ID: 16385517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased levels of transforming growth factor beta receptor type I and up-regulation of matrix gene program: A model of scleroderma.
    Pannu J; Gardner H; Shearstone JR; Smith E; Trojanowska M
    Arthritis Rheum; 2006 Sep; 54(9):3011-21. PubMed ID: 16947635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of interleukin-21 receptor in epidermis from patients with systemic sclerosis.
    Distler JH; Jüngel A; Kowal-Bielecka O; Michel BA; Gay RE; Sprott H; Matucci-Cerinic M; Chilla M; Reich K; Kalden JR; Müller-Ladner U; Lorenz HM; Gay S; Distler O
    Arthritis Rheum; 2005 Mar; 52(3):856-64. PubMed ID: 15751077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis.
    Chizzolini C; Raschi E; Rezzonico R; Testoni C; Mallone R; Gabrielli A; Facchini A; Del Papa N; Borghi MO; Dayer JM; Meroni PL
    Arthritis Rheum; 2002 Jun; 46(6):1602-13. PubMed ID: 12115192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased interleukin-17 production in patients with systemic sclerosis.
    Kurasawa K; Hirose K; Sano H; Endo H; Shinkai H; Nawata Y; Takabayashi K; Iwamoto I
    Arthritis Rheum; 2000 Nov; 43(11):2455-63. PubMed ID: 11083268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of type I collagen production by dermal fibroblasts upon contact with activated T cells: different sensitivity to inhibition between systemic sclerosis and control fibroblasts.
    Chizzolini C; Rezzonico R; Ribbens C; Burger D; Wollheim FA; Dayer JM
    Arthritis Rheum; 1998 Nov; 41(11):2039-47. PubMed ID: 9811060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast expression of the coactivator p300 governs the intensity of profibrotic response to transforming growth factor beta.
    Bhattacharyya S; Ghosh AK; Pannu J; Mori Y; Takagawa S; Chen G; Trojanowska M; Gilliam AC; Varga J
    Arthritis Rheum; 2005 Apr; 52(4):1248-58. PubMed ID: 15818659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunobiology of systemic sclerosis.
    Gu YS; Kong J; Cheema GS; Keen CL; Wick G; Gershwin ME
    Semin Arthritis Rheum; 2008 Oct; 38(2):132-60. PubMed ID: 18221988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-29, a key regulator of collagen expression in systemic sclerosis.
    Maurer B; Stanczyk J; Jüngel A; Akhmetshina A; Trenkmann M; Brock M; Kowal-Bielecka O; Gay RE; Michel BA; Distler JH; Gay S; Distler O
    Arthritis Rheum; 2010 Jun; 62(6):1733-43. PubMed ID: 20201077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of hepatocyte growth factor and its receptor (c-met) in skin fibroblasts from patients with systemic sclerosis.
    Kawaguchi Y; Harigai M; Hara M; Fukasawa C; Takagi K; Tanaka M; Tanaka E; Nishimagi E; Kamatani N
    J Rheumatol; 2002 Sep; 29(9):1877-83. PubMed ID: 12233882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of CD4+CD8+ double-positive T cells with very high interleukin-4 production potential in lesional skin of patients with systemic sclerosis.
    Parel Y; Aurrand-Lions M; Scheja A; Dayer JM; Roosnek E; Chizzolini C
    Arthritis Rheum; 2007 Oct; 56(10):3459-67. PubMed ID: 17907151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autocrine activation by interleukin 1alpha induces the fibrogenic phenotype of systemic sclerosis fibroblasts.
    Kawaguchi Y; McCarthy SA; Watkins SC; Wright TM
    J Rheumatol; 2004 Oct; 31(10):1946-54. PubMed ID: 15468358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast function in psoriatic arthritis. II. Increased expression of beta platelet derived growth factor receptors and increased production of growth factor and cytokines.
    Espinoza LR; Espinoza CG; Cuéllar ML; Scopelitis E; Silveira LH; Grotendorst GR
    J Rheumatol; 1994 Aug; 21(8):1507-11. PubMed ID: 7983655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous cytokine gene expression by cultured skin fibroblasts of systemic sclerosis. Correlation with collagen synthesis.
    Zurita-Salinas CS; Richaud-Patin Y; Krötzsch-Gómez E; Llorente L; Alcocer-Varela J; Díaz-de-León L; Palacios-Boix A
    Rev Invest Clin; 1998; 50(2):97-104. PubMed ID: 9658927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monocyte chemoattractant protein 3 as a mediator of fibrosis: Overexpression in systemic sclerosis and the type 1 tight-skin mouse.
    Ong VH; Evans LA; Shiwen X; Fisher IB; Rajkumar V; Abraham DJ; Black CM; Denton CP
    Arthritis Rheum; 2003 Jul; 48(7):1979-91. PubMed ID: 12847692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts.
    Wang Y; Fan PS; Kahaleh B
    Arthritis Rheum; 2006 Jul; 54(7):2271-9. PubMed ID: 16802366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.